High-Fructose Corn Syrup vs Blue Dye 1: which is worse?

What is High-Fructose Corn Syrup?

High-fructose corn syrup (HFCS) is a liquid sweetener produced by enzymatically converting a portion of corn syrup's glucose to fructose. The most common forms are HFCS-55 (55% fructose, 45% glucose, used primarily in beverages) and HFCS-42 (42% fructose, used in processed foods). It became dominant in the US food supply in the 1970s-1980s.

What is Blue Dye 1?

Blue Dye 1 (Brilliant Blue FCF) is a synthetic blue triarylmethane dye derived from petroleum. It produces a brilliant sky-blue color and is highly water-soluble. Unlike the azo dyes (Red 40, Yellow 5/6), Blue 1 belongs to the triarylmethane chemical class.

Documented risks

High-Fructose Corn Syrup: HFCS has been at the center of one of nutrition science's most contentious debates for 30+ years. The core concern is that fructose is metabolized differently than glucose: fructose is processed primarily in the liver where it can be converted to fat (de novo lipogenesis), contributing to non-alcoholic fatty liver disease (NAFLD) and elevated triglycerides. A landmark 2004 paper by Bray, Nielsen, and Popkin in the American Journal of Clinical Nutrition proposed that the increase in HFCS consumption from the 1970s tracked with rising obesity rates. This hypothesis was widely publicized but contested; subsequent controlled research found that HFCS and sucrose produce similar metabolic effects calorie-for-calorie. However, the broader research on fructose metabolism supports metabolic concerns. A 2012 PLOS ONE study (Basu et al.) found higher sugar-sweetened beverage consumption associated with increased rates of metabolic syndrome and type 2 diabetes. A 2012 Nature commentary by Lustig, Schmidt, and Brindis ('The Toxic Truth About Sugar') argued fructose's hepatic metabolism makes it uniquely harmful — prompting significant scientific debate. Key established effects of high fructose intake include: increased visceral fat, elevated blood triglycerides, increased uric acid (gout risk), worsened insulin resistance, and accelerated NAFLD progression. These effects occur with high fructose intake from any source (HFCS or sucrose), making HFCS no inherently worse than sucrose at equivalent doses — but its ubiquity in US processed foods contributes to chronically elevated fructose exposure at a population level. Mercury contamination: in 2009, independent testing by the Institute for Agriculture and Trade Policy (IATP) and a study in Environmental Health found mercury traces in some HFCS samples from certain manufacturers using mercury-grade caustic soda. The industry has largely transitioned to mercury-free processing since these findings.

Blue Dye 1: Blue Dye 1 was historically banned in several European countries before EU harmonization permitted it (as E133). EFSA's 2010 comprehensive safety re-evaluation found no evidence of carcinogenicity in standard animal tests. The ADI was set at 6 mg/kg body weight. The most significant documented safety concern for Blue 1 involves intravenous/enteral administration rather than dietary intake. In 2003, the FDA issued a Public Health Advisory warning against using Blue 1 (used as a food coloring agent in enteral nutrition formulas to detect aspiration in critically ill patients) after multiple case reports — including deaths — documented that Blue 1 can be absorbed through damaged intestinal mucosa and cause cardiovascular instability, metabolic acidosis, and death. The FDA advisory specifically warned against this clinical use in intensive care patients. This is a medical use concern, not a dietary intake concern. For healthy consumers eating normally, EFSA found no significant safety concerns at food use levels. Blue 1 was not included in the 2007 Lancet hyperactivity study. However, it falls under the FDA's April 2025 announcement to phase out all petroleum-based synthetic food dyes, reflecting updated policy on the class as a whole rather than specific Blue 1 data. Historically, Blue 1 was banned in multiple European countries due to safety concerns, though EU harmonization later permitted it with E-number labeling requirements. This history suggests precautionary concern even when formal regulatory action was not sustained.